UCL Business PLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

UCL Business PLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

UCL Business PLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
UCL Business PLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
37 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

UCL Business PLC (UCLB), a subsidiary of University College London (UCL), is a technology transfer company that supports and markets research and innovations of UCL. It provides the legal advice, commercial expertise, and administrative support. UCLB specializes in creating spinout businesses in new industries. It offer services from discovery disclosure to commercialisation strategy, contractual advice and formalization, business plan development, and through to incubation support, including identification of investors. UCLB also provide technology licensing, contract negotiation and project management services among others.

UCL Business PLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent d

  
Source:
Document ID
GDPH206207D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
UCL Business PLC, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
UCL Business PLC, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
UCL Business PLC, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
UCL Business PLC, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
UCL Business PLC, Medical Devices Deals, 2010 to YTD 201691
UCL Business PLC, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016102
UCL Business PLC, Pharmaceuticals &Healthcare, Deal Details1222
  Venture Financing121
    Orchard Therapeutics Raises USD31 Million in Series A Venture Financing121
    Puridify Raises USD3.4 Million in Series A Financing131
    Puridify Raises USD1.43 Million in Seed Funding141
    Canbex Therapeutics Raises US$3 Million In Venture Financing152
    Domainex Raises Funds In First Tranche Of US$2.3 Million Venture Financing Round172
    UCL Business Raises US$71 Million In First Round Financing191
  Partnerships201
    UCL Business Forms Joint Venture with Syncona201
    Cell Therapy Catapult Forms Catapult Therapy TCR with UCL Business and Imperial Innovations212
    UCL Ear Institute And UCL Business Enter Into Co-Developemnt Agreement With Autifony Therapeutics231
    UCL Business And National Centre for Young People Enters Into Commercialization Agreement With Special Products For Epistatus241
    AstraZeneca Enters Agreement With UCL Business To Develop Regenerative Medicines For Diabetic Retinopathy252
    AstraZeneca Enters Into Co-Development Agreement With University College London271
  Licensing Agreements281
    Autolus Enters into Licensing Agreement with UCL Business281
    Oxford Pharmascience Extends Licensing Agreement With UCL Business291
    Oxford Pharmascience Enters Into Licensing Agreement With UCL Business For Drug Delivery Technology301
    University College London Business Enters Into Licensing Agreement With TAP Biosystems For RAFT Technology311
    UCL Business Enters Into Licensing Agreement With Periowave Dental Technologies321
    AbD Serotec Enters Into An Agreement With UCL Business331
UCL Business PLC - Key Competitors341
Key Employees351
Locations And Subsidiaries361
  Head Office361
  Other Locations &Subsidiaries361
Appendix371
  Methodology371
  About GlobalData371
  Contact Us371
  Disclaimer371

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "UCL Business PLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/UCL-Business-PLC-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-23726>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). UCL Business PLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/UCL-Business-PLC-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-23726>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research